CEO Adrian Rawcliffe sold $35K of Adaptimmune Therapeutics Plc

Sold$35,416

$3.19Price

11,096Shares

−47%Stake

What ADAP did after the filing

Prices for ADAP after this filing aren't in yet.

Traded Tue, Jan 18. Filed Tue, Jan 18, 4:00 PM ET, after the close. Not investment advice.